Alphamab Oncology (STU:3NK) FCF Yield % : -5.91 (As of Dec. 13, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Alphamab Oncology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Alphamab Oncology's Trailing 12-Month Free Cash Flow is €-24.91 Mil, and Market Cap is €435.32 Mil. Therefore, Alphamab Oncology's FCF Yield % for today is -5.91%.

The historical rank and industry rank for Alphamab Oncology's FCF Yield % or its related term are showing as below:

STU:3NK' s FCF Yield % Range Over the Past 10 Years
Min: -12.55 Med: -6.66 Max: -3.04
Current: -5.91

During the past 7 years, the highest FCF Yield % of Alphamab Oncology was -3.04%. The lowest was -12.55%. And the median was -6.66%.

STU:3NK's FCF Yield % is ranked better than
65.03% of 1507 companies
in the Biotechnology industry
Industry Median: -13.02 vs STU:3NK: -5.91

Alphamab Oncology's FCF Margin % for the quarter that ended in Jun. 2024 was -29.30%.

Alphamab Oncology FCF Yield % Historical Data

The historical data trend for Alphamab Oncology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology FCF Yield % Chart

Alphamab Oncology Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-3.40

-5.00

-4.84

-4.30

Alphamab Oncology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial									-6.68	-4.93	-3.05	-5.16	-4.83

Competitive Comparison of Alphamab Oncology's FCF Yield %

For the Biotechnology subindustry, Alphamab Oncology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alphamab Oncology's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alphamab Oncology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Alphamab Oncology's FCF Yield % falls into.

Alphamab Oncology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Alphamab Oncology's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-30.697	/	713.20682
	=	-4.30%

Alphamab Oncology's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-6.513	*	2	/	269.91664
	=	-4.83%

Alphamab Oncology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Alphamab Oncology FCF Yield % Related Terms

Thank you for viewing the detailed overview of Alphamab Oncology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphamab Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (STU:3NK) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

09966:Hong Kong 3NK:Germany

Address

No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215127

Website

https://www.alphamabonc.com

Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in the discovery, development manufacturing, and commercialization of biotherapeutics for cancer treatment. Its product pipeline includes various drug candidates such as KN035 (Envida), KN046, KN026, JSKN003, and KN019 among others in different stages of development.

Alphamab Oncology Headlines

No Headlines